LinkedIn Icon
June 19-21, 2018
The Aloft Boston Seaport, Boston

Enabling Robust, Safe and Cost-Effective Production
of Highly Potent APIs

The 7th Annual HPAPI Summit will bring together perspectives from every stage of the drug development value chain – from bench to point of outsource – providing you with a unified outlook on the latest developments in highly potent compound development.

Incorporating insights from Pfizer, Genentech, Vertex, Biogen and Boehringer Ingelheim, this unique conference will delve into the scale-up, containment, risk-assessment, and outsourcing hurdles that need to be overcome to ensure your HPAPI development is robust, safe and cost-effective.

Join your colleagues at this event to ensure you’re up to speed with the most innovative potent compound handling approaches, and to prepare yourself to overcome any challenge complex potent compounds can pose.



“This conference is clearly the leader in the HPAPI arena. Without a doubt, I will be returning!”


"This conference can serve as both an incubator and catalyst to educate and harmonize across the industry."

Seattle Genetics

2017 Attendees Included:
2017 Attendees Update
Media Partner